Advertisement

Cancer Causes & Control

, 20:87 | Cite as

Reproductive factors and hormone use and risk of adult gliomas

  • Martha J. FeliniEmail author
  • Andrew F. Olshan
  • Jane C. Schroeder
  • Susan E. Carozza
  • Rei Miike
  • Terri Rice
  • Margaret Wrensch
Original Paper

Abstract

Previous research suggests there may be a hormonal influence on glioma risk as evidenced by lower rates in females, change in incidence rates around ages at menarche and menopause, and presence of hormone receptors in glial tumors. Using the large San Francisco Bay Area Adult Glioma Study, we investigated whether reported reproductive factors and hormone use were associated with gliomas overall or with histologic subtypes among female cases (n = 619) and controls (n = 650). We found that reproductive factors were generally not associated with gliomas. Weak to moderately elevated odds ratios were observed for self-reported later age at menarche (14+ vs. 12–13 years old: adjusted odds ratio (AOR) = 1.39, 95% confidence interval (CI): 1.02–1.89), particularly for non-glioblastoma histologies (AOR = 1.64, 95% CI: 1.11–2.43). Inverse associations were observed for ever self-reported use of exogenous hormones (oral contraceptive use: AOR = 0.72, 95% CI: 0.53–0.99; postmenopausal hormone use: AOR = 0.56, CI: 0.37–0.84). However, cumulative hormone exposure defined multiple ways demonstrated no clear pattern of association. The results of this study suggest that any protective effect of hormones on gliomas may be limited to exogenous hormones, but a more detailed history of exogenous hormone use is needed to confirm findings.

Keywords

Reproductive factors Gliomas Case–control study Exogenous hormone use 

Abbreviations

GBM

Glioblastoma

OR

Odds ratio

Notes

Acknowledgments

This research was supported in part by a grant from the National Institutes of Health: CA52689, CA097257, CA89032, ES06717, EX04705, and P30ES10126. Additional funding was provided by a gift from the Robert J. and Helen H. Glaser Family Foundation. The authors would like to thank Lucie McCoy for her technical assistance with the data.

References

  1. 1.
    Martinez-Cerdeno V, Noctor S, Kriegstein A (2006) Estradiol stimulates progenitor cell division in the ventricular and subventricular zones of the embryonic neocortex. Eur J Neurosci 24:3475–3488. doi: 10.1111/j.1460-9568.2006.05239.x PubMedCrossRefGoogle Scholar
  2. 2.
    Kuppers E, Ivanova T, Karolczak M, Lazarov N, Fohr K, Beyer C (2001) Classical and nonclassical estrogen action in the developing midbrain. Horm Behav 40:196–202. doi: 10.1006/hbeh.2001.1671 PubMedCrossRefGoogle Scholar
  3. 3.
    Marin R, Guerra B, Alonso R, Ramirez CM, Diaz M (2005) Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2:287–301. doi: 10.2174/156720205774322629 PubMedCrossRefGoogle Scholar
  4. 4.
    Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M (2007) ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49:391–402. doi: 10.1016/j.annemergmed.2006.07.932 PubMedCrossRefGoogle Scholar
  5. 5.
    Chamaon K, Stojek J, Kanakis D et al (2005) Micromolar concentrations of 2-methozyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J Neurooncol 72:11–16. doi: 10.1007/s11060-004-2158-4 PubMedCrossRefGoogle Scholar
  6. 6.
    Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ (2004) 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 213:57–65. doi: 10.1016/j.canlet.2004.04.021 PubMedCrossRefGoogle Scholar
  7. 7.
    Kang SH, Cho HT, Devi S et al (2006) Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 66:11991–11997. doi: 10.1158/0008-5472.CAN-06-1320 PubMedCrossRefGoogle Scholar
  8. 8.
    Dhandapani KM, Wade FM, Mahesh VB, Brann DW (2005) Astrocyte-derived transforming growth factor-β mediates the neuroprotective effects of 17 β-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146:2749–2759. doi: 10.1210/en.2005-0014 PubMedCrossRefGoogle Scholar
  9. 9.
    Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433–442PubMedGoogle Scholar
  10. 10.
    Yague JG, Lavaque E, Carretero J, Azcoitia I, Garcia-Segura LM (2004) Aromatase, the enzyme responsible for estrogen biosynthesis, is expressed by human and rat glioblastomas. Neurosci Lett 368:279–284. doi: 10.1016/j.neulet.2004.07.010 PubMedCrossRefGoogle Scholar
  11. 11.
    Gonzales A, Martinez-Campa C, Mediavilla MD et al (2007) Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells. Br J Cancer 97:755–760. doi: 10.1038/sj.bjc.6603935 CrossRefGoogle Scholar
  12. 12.
    Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population based study in Sweden. Int J Cancer 72:389–393. doi :10.1002/(SICI)1097-0215(19970729)72:3<389::AID-IJC2>3.0.CO;2-LPubMedCrossRefGoogle Scholar
  13. 13.
    Schlehofer B, Blettner M, Preston-Martin S et al (1999) Role of medical history in brain tumor development. Results from the International Adult Brain Tumor Study. Int J Cancer 82:155–160. doi :10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-PPubMedCrossRefGoogle Scholar
  14. 14.
    Ryan P, Lee M, North B, McMichael A (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51:20–27. doi: 10.1002/ijc.2910510105 PubMedCrossRefGoogle Scholar
  15. 15.
    Huang K, Whelan EA, Ruder AM et al (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13:1583–1588PubMedGoogle Scholar
  16. 16.
    Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa. Cancer Causes Control 4:505–511. doi: 10.1007/BF00052425 PubMedCrossRefGoogle Scholar
  17. 17.
    Cicuttini FM, Hurley SF, Forbes A et al (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71:203–207. doi :10.1002/(SICI)1097-0215(19970410)71:2<203::AID-IJC13>3.0.CO;2-IPubMedCrossRefGoogle Scholar
  18. 18.
    Hochberg F, Toniolo P, Cole P (1990) Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 8:55–60. doi: 10.1007/BF00182087 PubMedCrossRefGoogle Scholar
  19. 19.
    Hatch EE, Linet MS, Zhang J et al (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114:797–805. doi: 10.1002/ijc.20776 PubMedCrossRefGoogle Scholar
  20. 20.
    Silvera SA, Miller AB, Rohan TE (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118:1321–1324. doi: 10.1002/ijc.21467 PubMedCrossRefGoogle Scholar
  21. 21.
    Wigertz A, Lonn S, Mathiesen T et al (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629–636. doi: 10.1093/aje/kwj254 PubMedCrossRefGoogle Scholar
  22. 22.
    Benson VS, Pirie K, Green J, Casabonne D, Beral V (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. British J Cancer 99:185–190. doi: 10.1038/sj.bjc.6604445 CrossRefGoogle Scholar
  23. 23.
    Wrensch M, Lee M, Miike R et al (1997) Familial and personal medical history of cancer and nervous system conditions among adults with gliomas and controls. Am J Epidemiol 145:581–593PubMedGoogle Scholar
  24. 24.
    Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M (2002) History of allergies among adults with glioma and controls. Int J Cancer 98:609–615. doi: 10.1002/ijc.10239 PubMedCrossRefGoogle Scholar
  25. 25.
    Krishnan G, Felini M, Carozza SE, Miike R, Chew T, Wrensch M (2003) Occupation and adult gliomas in the San Francisco Bay Area. J Occup Environ Med 45:639–647. doi: 10.1097/01.jom.0000069245.06498.48 PubMedCrossRefGoogle Scholar
  26. 26.
    Geerlings MI, Muitenberg A, Witteman JC et al (2001) Reproductive period and risk of dementia in postmenopausal women. JAMA 285:1475–1481. doi: 10.1001/jama.285.11.1475 PubMedCrossRefGoogle Scholar
  27. 27.
    de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeter PH, Banga JD, van der Graaf Y (2002) Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 155:339–345. doi: 10.1093/aje/155.4.339 PubMedCrossRefGoogle Scholar
  28. 28.
    Jansen SC, Temme E, Scouten EG (2002) Lifetime estrogen exposure versus age at menopause as a mortality predictor. Maturitas 43:105–112. doi: 10.1016/S0378-5122(02)00183-4 PubMedCrossRefGoogle Scholar
  29. 29.
    Robins JM (2001) Data, design, and background knowledge in etiologic inference. Epidemiology 12:313–320. doi: 10.1097/00001648-200105000-00011 PubMedCrossRefGoogle Scholar
  30. 30.
    Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG (1990) Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163:1438–1444PubMedGoogle Scholar
  31. 31.
    Derby CA, Hume AL, McFarland M, McPhillips JB, Lasater TM, Carleton RA (1993) Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 137:1125–1135PubMedGoogle Scholar
  32. 32.
    Jung-Testas I, Baulieu EE (1998) Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J Steroid Biochem Mol Biol 65:243–251. doi: 10.1016/S0960-0760(97)00191-X PubMedCrossRefGoogle Scholar
  33. 33.
    Hopewell JW (1970) The effects of castration on the induction of experimental gliomas in male rats. Br J Cancer 24:187–190PubMedGoogle Scholar
  34. 34.
    Verzat C, Delisle M, Courrierre P, Hollande E (1990) Influence of host sex on growth of a human glioblastoma line in athymic mice. Neuropathol Appl Neurobiol 16:141–151. doi: 10.1111/j.1365-2990.1990.tb00943.x PubMedCrossRefGoogle Scholar
  35. 35.
    Plunkett RJ, Lis A, Barone TA, Fronckowiak MD, Greenberg SJ (1999) Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 90:1072–1077PubMedCrossRefGoogle Scholar
  36. 36.
    Avtsyn AP, Yablonovskaya LY (1964) Effects of disturbances in the hormonal status on experimental brain tumors. Acta Unio Int Contra Cancrum 20:1519–1522PubMedGoogle Scholar
  37. 37.
    Klauber N, Parangi S, Flynn E, Hamel E, D’Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81–86PubMedGoogle Scholar
  38. 38.
    Fotsis T, Zhang Y, Pepper MS et al (1994) The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368:237–239. doi: 10.1038/368237a0 PubMedCrossRefGoogle Scholar
  39. 39.
    LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691–3697PubMedGoogle Scholar
  40. 40.
    Bengtson NW, Linzer DI (2000) Inhibition of tumor growth by the antiangiogenic placental hormone proliferin-related protein. Mol Endocrinol 14(12):1934–1943. doi: 10.1210/me.14.12.1934 PubMedCrossRefGoogle Scholar
  41. 41.
    Greenland S, Rothman K (1998) Fundamentals of epidemiologic data analysis. Lippincott-Raven Publishers, Philadelphia, PA, pp 253–279Google Scholar
  42. 42.
    Bunin G, Spector L, Olshan A et al (2007) Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children’s Oncology Group. Am J Epidemiol 166(1):109–116. doi: 10.1093/aje/kwm050 PubMedCrossRefGoogle Scholar
  43. 43.
    Dhandapani KM, Brann D (2002) Estrogen-astrocyte interactions: implications for neuroprotection. BMC Neurosci 3:6–10. doi: 10.1186/1471-2202-3-6 PubMedCrossRefGoogle Scholar
  44. 44.
    McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 34:251–259PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Martha J. Felini
    • 1
    Email author
  • Andrew F. Olshan
    • 2
  • Jane C. Schroeder
    • 2
  • Susan E. Carozza
    • 3
  • Rei Miike
    • 4
  • Terri Rice
    • 4
  • Margaret Wrensch
    • 4
  1. 1.Department of EpidemiologyUniversity of North Texas Health Science CenterFort WorthUSA
  2. 2.Department of EpidemiologyUniversity of North CarolinaChapel HillUSA
  3. 3.Department of Epidemiology and BiostatisticsTAMHSC School of Rural Public HealthCollege StationUSA
  4. 4.Department of Neurological SurgeryUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations